Design and development of a swellable and mucoadhesive gastroretentive tablets of amoxycillin

An attempt has been made to develop a gastroretentive sustained release delivery system with swellable and mucoadhesive properties for a drug like amoxycillin that has gives localised action along with the added advantage of a common side effect like disturbance of colonic bacteria. Hydrophilic polymers like poly (ethylene oxide), hydroxypropyl cellulose and hydroxypropylmethyl cellulose were tried in combinations and statistically optimised. Formulations were evaluated for in vitro drug release profile, swelling characteristics and in vitro mucoadhesion property. Stability study was carried out to ensure the complete characterisation of the formulation. Gastroretentive ability was assured by in vivo study of non medicated tablet formulations by X-ray method. A 3 2 factorial design was used to optimize the formulation to get the release profile for upto 24 h. The in vitro drug release followed Weibull kinetics and the drug release mechanism was found to be of anomalous or non-Fickian type. The high water uptake leading to higher swelling of the tablet supported the anomalous release mechanism of amoxycillin. Also the mucoadhesion property values were satisfying. A formulation can be developed using swellable mucoadhesive biopolymers, which show excellent adhesion and gastroretention and desired release profiles thus providing temporal and spatial control.

[1]  R. Zelkó,et al.  The effect of storage and active ingredient properties on the drug release profile of poly(ethylene oxide) matrix tablets , 2008 .

[2]  J. Ali,et al.  Formulation and development of gastroretentive drug delivery system for ofloxacin. , 2006, Methods and findings in experimental and clinical pharmacology.

[3]  K. Picker-Freyer Polyethylene oxides , 2006 .

[4]  P. Vavia,et al.  Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. , 2006, International journal of pharmaceutics.

[5]  T. Güneri,et al.  Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans. , 2004, Farmaco.

[6]  A. Bernkop‐Schnürch,et al.  Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[7]  L. Maggi,et al.  Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. , 2002, Biomaterials.

[8]  Ram B. Gupta,et al.  Oral Sustained-Release Bioadhesive Tablet Formulation of Didanosine , 2001, Drug development and industrial pharmacy.

[9]  N. Peppas,et al.  Modeling of drug release from swellable polymers. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  N. Vakil,et al.  Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori , 1999, American Journal of Gastroenterology.

[11]  P. Maincent,et al.  Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[12]  E. Székely,et al.  [Eradication of Helicobacter pylori in peptic ulcer patients]. , 1999, Orvosi hetilap.

[13]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[14]  M. Tada,et al.  Mucoadhesive Microspheres Containing Amoxicillin for Clearance of Helicobacter pylori , 1998, Antimicrobial Agents and Chemotherapy.

[15]  C. Rhodes,et al.  Development of a Novel Controlled-Release System for Gastric Retention , 1997, Pharmaceutical Research.

[16]  S. Mortazavi,et al.  An investigation of some factors influencing the in vitro assessment of mucoadhesion , 1995 .

[17]  C J Kim,et al.  Drug release from compressed hydrophilic POLYOX-WSR tablets. , 1995, Journal of pharmaceutical sciences.

[18]  R. Cargill,et al.  Controlled Gastric Emptying. III. Gastric Residence Time of a Nondisintegrating Geometric Shape in Human Volunteers , 1993, Pharmaceutical Research.

[19]  P. Deasy,et al.  In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate , 1992 .

[20]  R. Gröning,et al.  Dosage forms with controlled gastrointestinal passage — studies on the absorption of nitrofurantoin , 1989 .

[21]  J. Robinson,et al.  Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. , 1985, Journal of pharmaceutical sciences.

[22]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[23]  J. Carstensen,et al.  Release mechanisms in gelforming sustained release preparations , 1979 .

[24]  J. A. Goldsmith,et al.  On methods of expressing dissolution rate data , 1978, The Journal of pharmacy and pharmacology.

[25]  F Langenbucher,et al.  Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution , 1972, The Journal of pharmacy and pharmacology.

[26]  T. Higuchi MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[27]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .

[28]  N. Peppas,et al.  Drug/Polymer Matrix Swelling and Dissolution , 2004, Pharmaceutical Research.

[29]  M. Tuncer,et al.  Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. , 1999, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[30]  C. Rhodes,et al.  Controlled-Release Drug Delivery Systems for Prolonged Gastric Residence: An Overview , 1996 .

[31]  N. Peppas Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.

[32]  R. Gröning,et al.  Oral Dosage Forms with Controlled Gastrointestinal Transit , 1984 .